Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies

PURPOSE: To explore the role of plasmatic platelet-activating factor acetylhydrolase (PAF-AH), a marker of cardiovascular risk, in patients with anti-phospholipid antibodies (aPL). METHODS: PAF-AH activity was assessed in a series of 167 unselected patients screened for aPL in a context of thromboti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabris, Martina, Cifù, Adriana, Pistis, Cinzia, Siega-Ducaton, Massimo, Fontana, Desrè Ethel, Giacomello, Roberta, Tonutti, Elio, Curcio, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365449/
https://www.ncbi.nlm.nih.gov/pubmed/28341873
http://dx.doi.org/10.1007/s13317-017-0092-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365449/
https://www.ncbi.nlm.nih.gov/pubmed/28341873
http://dx.doi.org/10.1007/s13317-017-0092-7

Ejemplares similares